![](https://cdn.prod.website-files.com/6642802e2a3f2f0af1170870/672e88498db5ce8764664744_Screenshot%202024-11-08%20at%201.52.43%20PM.png)
Inquis Medical Announces $40 Million Series B Financing to Accelerate Advancement of Aventus Thrombectomy System Addressing Venus Thromboembolic Diseases
MENLO PARK, Calif.--(BUSINESS WIRE)--Inquis Medical, a pioneering medical technology company specializing in advanced thrombectomy systems, today announced the successful closure of its $40 million Series B financing round.